Squarepoint
NAUT icon

Squarepoint’s Nautilus Biotechnolgy NAUT Stock Holding History

Squarepoint’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1K Buy
+33,746
New +$89.1K ﹤0.01% 4255
2026
Q1 		– Sell
-11,316
Closed -$22.1K – 4711
2025
Q4 		$22.1K Sell
11,316
-120,511
-91% -$198K ﹤0.01% 4163
2025
Q3 		$111K Buy
131,827
+30,005
+29% +$22.1K ﹤0.01% 4090
2025
Q2 		$73.8K Buy
101,822
+77,923
+326% +$58.5K ﹤0.01% 4240
2025
Q1 		$20.6K Sell
23,899
-2,425
-9% -$3.6K ﹤0.01% 4435
2024
Q4 		$44.2K Buy
+26,324
New +$63K ﹤0.01% 4864
2022
Q2 		– Sell
-42,626
Closed -$185K – 3202
2022
Q1 		$185K Buy
+42,626
New +$175K ﹤0.01% 2497

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Squarepoint's NAUT Position: Q2 2026 in Review

Squarepoint opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 33,746 shares worth $63.1K. The stake represents ﹤0.01% of the portfolio and ranks #4255 among its holdings. This is a return to the name: Squarepoint previously reported a position in NAUT as recently as Q4 2025.

Squarepoint first reported a position in NAUT in Q1 2022 and has held it in 7 quarters since. The position peaked at $185K in Q1 2022. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Squarepoint held 33,746 shares of Nautilus Biotechnolgy worth $63.1K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Squarepoint position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4255 holding.
  • Squarepoint first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 7 quarters since.
  • Squarepoint's Nautilus Biotechnolgy position peaked at $185K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.